Form 8-K - Current report:
SEC Accession No. 0001698530-24-000136
Filing Date
2024-12-11
Accepted
2024-12-11 17:17:01
Documents
15
Period of Report
2024-12-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20241209.htm   iXBRL 8-K 32153
2 EX-10.1 exhibit101_cspa12924.htm EX-10.1 181801
3 EX-10.2 exhibit102_rra12924.htm EX-10.2 209493
  Complete submission text file 0001698530-24-000136.txt   615260

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20241209.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20241209_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20241209_pre.xml EX-101.PRE 12512
17 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20241209_htm.xml XML 2706
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 241542406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)